These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 36425101

  • 21. The Polymorphisms of Interleukin-12B Gene and Susceptibility to Inflammatory Bowel Diseases: A Meta-analysis and Trial Sequential Analysis.
    Wang J, Liu H, Wang Y, Wu J, Wang C, Liu K, Qin Q.
    Immunol Invest; 2021 Nov; 50(8):987-1006. PubMed ID: 33390082
    [Abstract] [Full Text] [Related]

  • 22. Periodontitis prevalence and severity in inflammatory bowel disease: A case-control study.
    Baima G, Muwalla M, Testa G, Mazza F, Bebars A, Perotto S, Vernero M, Massano A, Romano F, Ribaldone DG, Aimetti M.
    J Periodontol; 2023 Mar; 94(3):313-322. PubMed ID: 36111636
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Global Prevalence and Bidirectional Association Between Psoriasis and Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.
    Alinaghi F, Tekin HG, Burisch J, Wu JJ, Thyssen JP, Egeberg A.
    J Crohns Colitis; 2020 Mar 13; 14(3):351-360. PubMed ID: 31504363
    [Abstract] [Full Text] [Related]

  • 27. Inflammatory bowel disease as a risk factor for periodontitis under Taiwanese National Health Insurance Research database.
    Yu HC, Chen TP, Chang YC.
    J Dent Sci; 2018 Sep 13; 13(3):242-247. PubMed ID: 30895127
    [Abstract] [Full Text] [Related]

  • 28. Periodontitis and inflammatory bowel disease: a meta-analysis.
    She YY, Kong XB, Ge YP, Liu ZY, Chen JY, Jiang JW, Jiang HB, Fang SL.
    BMC Oral Health; 2020 Mar 12; 20(1):67. PubMed ID: 32164696
    [Abstract] [Full Text] [Related]

  • 29. Unveiling the Ghrelin and Obestatin Roles in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis Assessing Their Pathogenic Implications and Biomarker Utility.
    Khalaji A, Babajani N, Amirsardari Z, Saeedian B, Peiman S, Berger NA, Behnoush AH.
    Inflamm Bowel Dis; 2024 Apr 03; 30(4):629-640. PubMed ID: 37669127
    [Abstract] [Full Text] [Related]

  • 30. Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease.
    Jayasooriya N, Baillie S, Blackwell J, Bottle A, Petersen I, Creese H, Saxena S, Pollok RC, POP-IBD study group.
    Aliment Pharmacol Ther; 2023 Mar 03; 57(6):635-652. PubMed ID: 36627691
    [Abstract] [Full Text] [Related]

  • 31. Immunological Traits of Patients with Coexistent Inflammatory Bowel Disease and Periodontal Disease: A Systematic Review.
    de Mello-Neto JM, Nunes JGR, Tadakamadla SK, da Silva Figueredo CM.
    Int J Environ Res Public Health; 2021 Aug 25; 18(17):. PubMed ID: 34501547
    [Abstract] [Full Text] [Related]

  • 32. The Bidirectional Association between Inflammatory Bowel Disease and Atopic Dermatitis: A Systematic Review and Meta-Analysis.
    Shi X, Chen Q, Wang F.
    Dermatology; 2020 Aug 25; 236(6):546-553. PubMed ID: 31955167
    [Abstract] [Full Text] [Related]

  • 33. Inflammatory bowel disease and oral health: systematic review and a meta-analysis.
    Papageorgiou SN, Hagner M, Nogueira AV, Franke A, Jäger A, Deschner J.
    J Clin Periodontol; 2017 Apr 25; 44(4):382-393. PubMed ID: 28117909
    [Abstract] [Full Text] [Related]

  • 34. Risk of venous thromboembolism in children and adolescents with inflammatory bowel disease: A systematic review and meta-analysis.
    Zhang XY, Dong HC, Wang WF, Zhang Y.
    World J Gastroenterol; 2022 Apr 28; 28(16):1705-1717. PubMed ID: 35581968
    [Abstract] [Full Text] [Related]

  • 35. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
    Miao XP, Li JS, Ouyang Q, Hu RW, Zhang Y, Li HY.
    Cochrane Database Syst Rev; 2014 Oct 23; 2014(10):CD007744. PubMed ID: 25340915
    [Abstract] [Full Text] [Related]

  • 36. Health-related quality of life aspects of the 'Periodontitis prevalence in ulcerative colitis and Crohn's disease' (PPCC) cohort.
    Bertl K, Tsakos G, Pandis N, Bogren A, Burisch J, Stavropoulos A.
    J Clin Periodontol; 2023 Dec 23; 50(12):1601-1620. PubMed ID: 37670508
    [Abstract] [Full Text] [Related]

  • 37. Oral Health Status in Patients with Inflammatory Bowel Diseases: A Systematic Review.
    Nijakowski K, Gruszczyński D, Surdacka A.
    Int J Environ Res Public Health; 2021 Nov 02; 18(21):. PubMed ID: 34770034
    [Abstract] [Full Text] [Related]

  • 38. Interventions for fatigue in inflammatory bowel disease.
    Farrell D, Artom M, Czuber-Dochan W, Jelsness-Jørgensen LP, Norton C, Savage E.
    Cochrane Database Syst Rev; 2020 Apr 16; 4(4):CD012005. PubMed ID: 32297974
    [Abstract] [Full Text] [Related]

  • 39. Crohn's Disease is a Greater Risk Factor for Nonalcoholic Fatty Liver Disease Compared to Ulcerative Colitis: A Systematic Review.
    Kodali A, Okoye C, Klein D, Mohamoud I, Olanisa OO, Parab P, Chaudhary P, Mukhtar S, Moradi A, Hamid P.
    Cureus; 2023 Aug 16; 15(8):e42995. PubMed ID: 37671212
    [Abstract] [Full Text] [Related]

  • 40. Inflammatory bowel disease and risk of dementia: An updated meta-analysis.
    Liu N, Wang Y, He L, Sun J, Wang X, Li H.
    Front Aging Neurosci; 2022 Aug 16; 14():962681. PubMed ID: 36275009
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.